Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies
Clinical trial NCT02985554 · TERMINATED
Trial details
- NCT number
- NCT02985554
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2019-02-06
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.